Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study

BACKGROUND: Circulating tumour cells (CTC) in the blood have been accepted as a prognostic marker in patients with metastatic colorectal cancer (CRC). Only limited data exist on the prognostic impact of CTC in patients with early stage CRC using standardised detection assays. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bork, U, Rahbari, N N, Schölch, S, Reissfelder, C, Kahlert, C, Büchler, M W, Weitz, J, Koch, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402459/
https://www.ncbi.nlm.nih.gov/pubmed/25867263
http://dx.doi.org/10.1038/bjc.2015.88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402459/
https://www.ncbi.nlm.nih.gov/pubmed/25867263
http://dx.doi.org/10.1038/bjc.2015.88

Ejemplares similares